Navigation Links
OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities
Date:11/17/2009

ALISO VIEJO, Calif., Nov. 17 /PRNewswire/ -- OCTANe hosted nearly 700 leading medical device industry executives from over 425 companies to discuss promising technology and emerging trends for the medical device industry last week at the 4th Annual CA Medical Device & Investor Forum.

For the first time on one stage, company leaders from the biggest M&A transactions in Orange County history discussed the details of the deals, and why Orange County is a hotbed for this type of activity. Stephen Oesterle, MD, senior vice president for medicine and technology at Medtronic expressed that large companies like Medtronic will continue to acquire, and that they rely on the innovations of smaller companies and start-ups. Dr. Oesterle was joined by Dan Lamaitre from CoreValve, Jim Mazzo from AMO, Sean Murphy from Abbott and Charles Warden from Versant Ventures.

"This panel of industry stars was an excellent foundation on which the rest of the conference was built," said Matthew Jenusaitis, president and CEO of OCTANe. "The relationship between large companies, emerging growth companies, and the investment world is more important than ever, and this panel reflected OCTANe's mission of stimulating the innovation ecosystem in our region."

More than nine countries and 19 states were represented at the Forum, and on the second day of the conference attendees chose between eight educational panels covering industry insights to cardiovascular, ophthalmology and healthcare IT, device design, IP due diligence, regulatory approvals, and global opportunities. Concurrently, 11 start-ups gave investment presentations, featuring new businesses and technologies in critical areas like orthopedic, breast health, and the neuro interventional market, among others.

The lunch keynote spotlighted Healthcare Policy and Reform, and featured Christopher Cox, former SEC Chairman, as well as other leading DC experts. This discussion was followed by the keynote Investor Panel with Dr. Thomas Fogarty, a cardiovascular surgeon and world-renowned inventor, and leaders from New Leaf, Piper Jaffray, and De Novo Ventures.

Select panel slides, videos, photos and webcasts are available for review at www.octaneforum2009.com.

About OCTANe:

OCTANe is fueling "innovation development" in Orange County and Southern California. By connecting people, capital and technology, OCTANe accelerates entrepreneurs and company development for Orange County's biomedical and technology communities. The organization brings together the region's leading biomedical and information technology companies, promising startups, entrepreneurs, venture capitalists, and universities to help create, grow, support, staff and fund innovative companies. For more information, visit www.octaneoc.org.

    Media Contact: Cynthia Bemis, (949) 330-6566
                   Cynthia.Bemis@octaneoc.org

SOURCE OCTANe


'/>"/>
SOURCE OCTANe
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results
2. Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference
3. Cardo Medical, Inc. Announces Closing of $6.2 Million Private Placement
4. Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient
5. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
6. CardioGenics Holdings Inc. Featured in Medical Device Daily
7. Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014
8. Pulmo BioTech Inc. Announces that Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Shows Early Indications of Being Able to Diagnose a Wide Range of Medical Conditions Affecting the Physical and/or Biological Integrity of the Pulmon
9. Cardio Vascular Medical Device Launches Corporate Website
10. Sutter Medical Center Receives Certification to Use Ventricular Assist Devices as Destination Therapy
11. Jefferson Radiology Acquires Two Medical Imaging Center Offices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):